Recently an enzyme catalyzing glycosylation, B4GALNT2, has been associated with increased susceptibility to Salmonella infection [23], while its expression has been reported to be downregulated in colon cancer compared with normal mucosa [24]. Here, B4GALNT2 is linked to colonic neoplasm.